Chronic mesenteric ischaemia

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Chronic mesenteric ischaemia occurs when meal-induced intestinal blood demand exceeds supply, most often from atherosclerotic stenosis at the coeliac and superior mesenteric artery origins. Extensive collateral circulation means many people remain asymptomatic until more than one vessel is affected, although haemodynamically important single-vessel disease can be symptomatic in selected cases. Less common causes include median arcuate ligament compression, vasculitis and non-atherosclerotic arteriopathy, which require different interpretation.

The classic patient reduces meal size to avoid pain and becomes malnourished. Nausea, diarrhoea or constipation can lead to labels of peptic disease, gallstones or IBS. A history of smoking, coronary, cerebral or peripheral arterial disease raises probability. However, pancreatic and gastric cancer, peptic disease, biliary pain and chronic pancreatitis are common dangerous mimics; vascular imaging and appropriate luminal or cancer investigation may need to run in parallel.

Revascularisation is recommended for a credible symptomatic syndrome to relieve pain, restore intake and prevent infarction. Endovascular stenting offers lower initial physiological burden but may restenose; open bypass can provide durability but has greater operative cost. Anatomy, frailty, previous intervention and local outcomes determine choice. Severe malnutrition increases procedural risk, yet delaying flow restoration for prolonged feeding can provoke worsening postprandial ischaemia, so nutrition and revascularisation are coordinated.

Key points

Typical chronic mesenteric ischaemia causes reproducible postprandial epigastric or central pain, food fear and progressive weight loss in a person with systemic atherosclerotic risk.
Symptoms often begin 15 to 30 minutes after eating and can last hours; smaller meals reduce demand and may temporarily mask the disease.
A bruit is neither sensitive nor specific. Normal examination, endoscopy or routine blood tests do not exclude flow-limiting mesenteric disease.
CTA is the usual anatomical first-line test, showing coeliac and superior mesenteric origins, collateral pathways, calcification and competing abdominal disease.
Single-vessel stenosis is common and can be incidental; symptom concordance, severity, multivessel involvement and exclusion of alternatives determine causality.
Sudden persistent pain, peritonism, gastrointestinal bleeding or metabolic deterioration suggests acute-on-chronic ischaemia and requires emergency CTA and surgery.
Definitive treatment restores flow with endovascular or open revascularisation; nutritional supplements alone cannot overcome demand ischaemia.
Smoking cessation, antiplatelet therapy, lipid lowering, blood-pressure and diabetes care continue after intervention because this is systemic atherosclerosis.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Atherosclerotic stenosis

Progressive narrowing of the coeliac and mesenteric artery origins is the usual cause, often accompanying smoking and established cardiovascular disease elsewhere.

Non-atherosclerotic arteriopathy

Vasculitis, dissection, fibromuscular disease and external vascular compression are less common causes considered when age or imaging is atypical.

Low-flow susceptibility

Cardiac failure, hypotension and limited collaterals can expose marginal mesenteric reserve, worsening symptoms despite no new fixed occlusion.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Restricted resting inflow
Multivessel stenosis limits the capacity of mesenteric arteries and collaterals to maintain intestinal perfusion when metabolic demand rises.
2
Postprandial demand mismatch
Digestion increases bowel oxygen demand, but flow cannot rise sufficiently, causing reproducible pain after eating and progressive food avoidance.
3
Acute-on-chronic thrombosis
Plaque rupture or worsening low flow can abruptly occlude a critically narrowed vessel, converting chronic symptoms into bowel infarction.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Mesenteric angina

Reproducible central or epigastric pain after meals with food avoidance and objective weight loss is the core phenotype, especially with smoking or other arterial disease.

Systemic atherosclerosis

Coronary disease, stroke, claudication, renal artery disease, absent pulses or vascular bruits increase probability and mandate broad secondary prevention.

Acute-on-chronic eventRed flag

Pain becomes sudden, severe, continuous or disproportionate, with vomiting, blood, guarding, acidosis or shock. Treat as acute mesenteric ischaemia immediately.

Severe malnutritionRed flag

Sarcopenia, dehydration, deficiency, frailty or inability to eat increases procedural risk and requires dietetic support without postponing definitive vascular assessment.

Non-atherosclerotic clue

A younger patient without vascular risk, inflammatory features, positional pain or isolated coeliac compression needs specialist consideration of vasculitis or median arcuate ligament syndrome rather than automatic stenting.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
CT angiographyFirst step
Why
Map coeliac, SMA and IMA stenosis or occlusion, calcification, collateral vessels and bowel or alternative abdominal pathology.
Interpretation and limitations
Anatomical stenosis requires symptom correlation; multivessel severe disease is more persuasive, while incidental single-vessel narrowing is common.
02
Mesenteric duplex ultrasound
Why
Assess fasting flow velocities in an experienced vascular laboratory for screening or surveillance without contrast or radiation.
Interpretation and limitations
Bowel gas, obesity, respiration and operator technique limit accuracy; an abnormal or non-diagnostic study usually requires CTA or MRA.
03
MR angiography
Why
Provide vascular mapping when CTA contrast or radiation is problematic and local expertise can obtain a diagnostic study.
Interpretation and limitations
Longer acquisition and lower spatial detail for calcification or smaller branches may limit use; it is unsuitable for an unstable acute-on-chronic presentation.
04
Nutrition and baseline blood profile
Why
Measure weight trajectory, intake, MUST, FBC, renal and liver profile, glucose, lipids, ferritin, albumin and electrolytes before intervention.
Interpretation and limitations
Normal tests do not exclude disease. Low albumin is inflammatory and prognostic rather than a specific calorie marker.
05
Alternative-diagnosis assessment
Why
Use current cancer referral, gastroscopy, pancreatic or biliary imaging, faecal testing and coeliac serology according to symptoms and red flags.
Interpretation and limitations
A negative endoscopy does not prove vascular disease, and an incidental stenosis should not close the malignancy pathway.
06
Catheter angiography
Why
Define and treat lesions when endovascular intervention is planned or non-invasive imaging is discordant.
Interpretation and limitations
It is invasive and usually therapeutic rather than the first diagnostic test; access, embolic and contrast risks require consent.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Gastrointestinal malignancy

Weight loss, anaemia, progressive symptoms or a mass warrants cancer investigation; mesenteric angina is especially suggested by reproducible meal-linked pain and vascular disease.

Chronic pancreatitis

Back-radiating pain, calcification, ductal change and exocrine insufficiency favour pancreatic disease over arterial stenosis on angiographic imaging.

Peptic or biliary disease

Ulceration on endoscopy or episodic right-upper-quadrant pain with gallstones offers a structural explanation, whereas incidental gallstones alone may mislead.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01RecognisePostprandial pain and weight lossFirst stepA patient has reproducible meal-related pain, food fear or unexplained weight loss with vascular risk.

1Assess acute-on-chronic warning signs and use emergency CTA if pain is persistent, disproportionate or accompanied by peritonism or organ dysfunction.
2For a stable syndrome, request CTA and evaluate cancer, pancreatic, peptic and biliary alternatives in parallel according to the phenotype.
3Start dietetic support with small energy-dense intake and refeeding precautions when needed, without allowing supplements to delay vascular review.
4Refer promptly to a vascular multidisciplinary service with the images and functional nutrition impact.

02RestoreSymptomatic flow-limiting diseaseClinical and imaging evidence support chronic mesenteric ischaemia.

1Confirm the target vessel, collateral anatomy and procedural risk at a vascular, interventional and surgical MDT.
2Select endovascular stenting or open bypass based on anatomy, durability, frailty, prior treatment and local expertise.
3Coordinate peri-procedural antiplatelet, renal protection, nutrition and anaesthesia plans.
4After reperfusion advance intake, monitor for reperfusion injury and establish restenosis surveillance.

03PreventSystemic vascular protectionAtherosclerotic chronic mesenteric ischaemia is suspected or confirmed.

1Offer smoking-cessation support and treat blood pressure, diabetes and lipid risk under current NICE guidance.
2Use antiplatelet therapy unless contraindicated, with a procedure-specific plan after stenting or bypass.
3Encourage activity and adequate nutrition after perfusion is restored, rather than provoking pain with unsupported meal advice beforehand.
4Monitor other coronary, cerebrovascular, peripheral and renal arterial disease and ensure urgent access for recurrent postprandial or acute pain.

Key medicines and prescribing safety3 treatments · regimens, roles and cautions

Reduces systemic and target-vessel arterial thrombosis risk in atherosclerotic disease.

Antiplatelet therapy

Use the current BNF and vascular-team regimen, commonly single antiplatelet before intervention and a device-specific plan after stenting.

Gastrointestinal bleeding, allergy and concurrent anticoagulation require review. Do not improvise dual-therapy duration; the intervention team owns it.

Reduces systemic cardiovascular events and helps stabilise atherosclerotic plaque.

High-intensity statin

Use the current NICE NG238 secondary-prevention regimen and titrate to response, interactions and tolerance.

Review muscle symptoms, liver context and major interactions; do not stop after revascularisation because the systemic disease persists.

Treats malnutrition and improves procedural recovery while definitive perfusion treatment is arranged.

Balanced nutritional support

Dietitian-calculated oral or enteral energy and protein in small divided portions, with cautious refeeding when high risk and parenteral support only when the gut route is inadequate or unsafe.

Large meals can provoke pain before revascularisation. Nutrition alone does not correct flow, and aggressive feeding can cause refeeding syndrome.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Severe malnutrition

Food fear and reduced meal size cause weight loss, sarcopenia and micronutrient deficits, increasing procedural risk before revascularisation.

Acute bowel infarction

Superimposed thrombosis can cause sudden severe pain, necrosis, perforation and sepsis requiring emergency revascularisation and bowel resection.

Systemic atherosclerotic events

The same vascular burden increases myocardial infarction, stroke and limb-ischaemia risk, making cardiovascular secondary prevention part of disease management.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Track pain timing, food avoidance, weight, muscle function and actual intake before and after revascularisation.
Monitor renal function around CTA and intervention while avoiding diagnostic delay in acute deterioration.
Review access site, distal perfusion, abdominal pain and inflammatory markers after endovascular or open treatment.
Use duplex or CTA surveillance at the vascular service interval and investigate recurrent symptoms promptly for restenosis.
Monitor antiplatelet bleeding, statin tolerance, blood pressure, HbA1c and lipids as part of systemic vascular prevention.
Reassess cancer and gastrointestinal alternatives if pain persists despite technically successful revascularisation.
Provide explicit emergency advice for sudden persistent pain, vomiting, bleeding or collapse.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Food fear is adaptive evidence

Patients discover that eating provokes pain and unconsciously reduce portions. The behaviour is a physiological clue, not simply anxiety.

Stenosis can be incidental

Atherosclerosis commonly affects mesenteric origins. Treatment requires a credible symptom-anatomy relationship, not an imaging percentage alone.

Normal endoscopy is compatible

Mucosal inspection between attacks may be normal because the disease is flow-limited and demand-dependent.

Nutrition and flow are linked

Large caloric challenges increase splanchnic demand before reperfusion, while prolonged starvation increases operative risk; coordinate both rather than choosing one.

Acute change resets the clock

A stable chronic work-up becomes an emergency when pain turns continuous or systemic signs appear.

11Common pitfallsFrequent interpretation and management errors.

01
Labelling postprandial weight-loss pain IBS without vascular assessment.
02
Stenting an incidental single-vessel lesion without symptom concordance.
03
Waiting for malnutrition to resolve completely before restoring flow.
04
Using a normal gastroscopy to exclude mesenteric disease.
05
Omitting cancer and pancreatic alternatives because CTA shows atherosclerosis.
06
Failing to provide acute-on-chronic emergency advice.